Clinical trial
A Biomarker-directed Study of XPro1595 in Patients With Alzheimer's
NCT03943264
Study timeline
Study start (actual)2019-11-20Date precision: day
Registry last updated2023-06-15
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Alzheimer Diseaseunresolved
Interventions
XPro1595DRUG
Sponsors & collaborators
Inmune Bio, Inc.lead sponsor
Alzheimer's Associationcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03943264 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.